REFERENCES
Polson RJ, Misiewicz JJ: Non-nutritional management of inflammatory disease. Bailliere's Clin Gastroenterol 6:1–26, 1992
Summers RW, Switz DM, Sessions JT, Becktel JM, Best WR, Kern F, Singleton JW: National cooperative Crohn's disease study: Results of drug treatment. Gastroenterology 77:847–869, 1979
Rosenberg JL, Levin B, Wall AJ, Kirsner JB: A controlled trial of azathioprine in Crohn's disease. Am J Dig Dis 20:721–726, 1975
Willoughby JMT, Beckett J, Kumar PJ, Dawson AM: Controlled trial of azathioprine in Crohn's disease. Lancet 2:944–947, 1971
Blichfield P, Blomhoff JP, Myhre E, Gjone E: Metronidazole in Crohn's disease. A double blind crossover clinical trial. Scand J Gastroenterol 13:123–127, 1978
Brandt I, Bernstein LH, Boley SJ, Frank MS: Metronidazole therapy for perineal Crohn's disease: A follow-up study. Gastroenterology 83:383–387, 1982
Van Hees PAM, Van Lier HJJ, Van Elteren PH, Driessen WMM, Van Hogezand RA, Ten Velde GPM, Bakker JH, Van Tongeren JHM: Effect of sulphasalazine in patients with active Crohn's disease: a controlled double-blind study. Gut 22:404–409, 1981
Mitchell IC, Turk JL: Effect of the immune modulating agents cyclophosphamide, methotrexate, hydrocortisone, and cyclosporin A on an animal model of granulomatous bowel disease. Gut 31:674–678, 1990
Gudbjornsson B, Hallgren R: Cutaneous polyarthritis nodosa associated with Crohn's disease. Report and review of the literature. J Rheumatol 17:386–390, 1990
Gerber NL, Steinberg AD: Clinical use of immunosuppressive drugs: Part I. Drugs 11:14–35, 1976
Gerber NL, Steinberg AD: Clinical use of immunosuppressive drugs: Part II. Drugs 11:90–112, 1976
Rights and permissions
About this article
Cite this article
Rieger, N., Stahl, J. & Wattchow, D. Case Report: Intractable Crohn's Colitis and Perianal Disease Responding to Cyclophosphamide and Epirubicin. Dig Dis Sci 42, 2367–2369 (1997). https://doi.org/10.1023/A:1018843507275
Issue Date:
DOI: https://doi.org/10.1023/A:1018843507275